Sygnature further enhances capabilities and services within the translational sciences.

14th December 2016 – Nottingham, UK – Sygnature Discovery has released a biology publication focusing on our collaboration with Corcept Therapeutics. This work highlights our biomarker validation work and reports the outcome of phase I QBR116598 study that was also recently presented at Sygnature by Quotient clinical. The publication, sets the scene to support further […]

Sygnature Discovery expands DMPK team with appointment of Dr. Edward Browne

12th October 2016 – Nottingham, UK – Sygnature announces the expansion of its DMPK team with the appointment of Dr Ed Browne as Associate Director of DMPK. Ed is an experienced drug discovery scientist who brings a thorough understanding of developing and prosecuting a lead optimisation strategy, having worked at GSK, Singapore for the last […]

Sygnature Discovery and Viramatix announce anti-viral drug discovery strategic alliance

5th October 2016 – Nottingham, UK and Kuala Lumpur, Malaysia – Sygnature Discovery Limited, the UK’s largest independent provider of integrated drug discovery resources and expertise, and Viramatix Sdn. Bhd., a biopharmaceutical company involved in the discovery of peptide based anti-viral therapeutics, today announced their ongoing collaboration on innovative anti-influenza therapeutics.   Influenza virus infection […]

The Corona sculpture starts to take shape on the new ‘Discovery’ building

3rd October 2016 – Nottingham, UK – Sygnature Discovery today saw the start of the Brise Soleil installation on the front of the new £30m ‘Discovery’ building. which will reduce the risk of the building overheating. The sculpture known as Corona forms a curtain of metal tubes 17 metres high across the front of the […]

Sygnature is exhibiting at ELRIG’s Drug Discovery 2016 event at the ACC, Liverpool. Stand G1

13th and 14th October 2016 – Liverpool, UK – Drug Discovery 2016 will bring together 1000 delegates and 50 world-class speakers from academia and industry, each representing critical areas in drug discovery. Scientific Sessions: Innovations in Chemistry Oncology & Immunology Innovations in Predictive & Translational Models Assay Development, Screening & Emerging Technologies Coming Closer to […]

Page 7 of 15« First...56789...Last »
Copyright © 2018 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.